Insights

Loading spinner
Gathering insights about Medicines for Europe

Similar companies to Medicines for Europe

Medicines for Europe Tech Stack

Medicines for Europe uses 8 technology products and services including Open Graph, Microsoft Excel, Microsoft 365, and more. Explore Medicines for Europe's tech stack below.

  • Open Graph
    Content Management System
  • Microsoft Excel
    Editors
  • Microsoft 365
    Email
  • JSON-LD
    Javascript Frameworks
  • MixItUp
    Javascript Frameworks
  • SweetAlert2
    Javascript Libraries
  • PHP
    Programming Languages
  • Apache
    Web Servers

Media & News

Medicines for Europe's Email Address Formats

Medicines for Europe uses at least 1 format(s):
Medicines for Europe Email FormatsExamplePercentage
FLast@medicinesforeurope.comJDoe@medicinesforeurope.com
38%
First@medicinesforeurope.comJohn@medicinesforeurope.com
12%
FLast@medicinesforeurope.comJDoe@medicinesforeurope.com
38%
First@medicinesforeurope.comJohn@medicinesforeurope.com
12%

Frequently Asked Questions

What is Medicines for Europe's official website and social media links?

Minus sign iconPlus sign icon
Medicines for Europe's official website is medicinesforeurope.com and has social profiles on LinkedIn.

What is Medicines for Europe's NAICS code?

Minus sign iconPlus sign icon
Medicines for Europe's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Medicines for Europe have currently?

Minus sign iconPlus sign icon
As of December 2025, Medicines for Europe has approximately 60 employees across 1 continents, including Europe. Key team members include Head Of Communications And Stakeholder Relations: K. O.Vice President: S. S.Deputy Director General, Head Of Regulatory Affairs Medicines For Europe: B. S.. Explore Medicines for Europe's employee directory with LeadIQ.

What industry does Medicines for Europe belong to?

Minus sign iconPlus sign icon
Medicines for Europe operates in the Pharmaceutical Manufacturing industry.

What technology does Medicines for Europe use?

Minus sign iconPlus sign icon
Medicines for Europe's tech stack includes Open GraphMicrosoft ExcelMicrosoft 365JSON-LDMixItUpSweetAlert2PHPApache.

What is Medicines for Europe's email format?

Minus sign iconPlus sign icon
Medicines for Europe's email format typically follows the pattern of FLast@medicinesforeurope.com. Find more Medicines for Europe email formats with LeadIQ.

When was Medicines for Europe founded?

Minus sign iconPlus sign icon
Medicines for Europe was founded in 1993.

Medicines for Europe

Pharmaceutical ManufacturingBrussels, Belgium51-200 Employees

Medicines for Europe represents the generic, biosimilar and value-added medicines industries across Europe. Its vision is to provide sustainable access to high quality medicines, based on 5 important pillars: patients, quality, value, sustainability and partnership. Its members directly employ 190,000 people at over 400 manufacturing and 126 R&D sites in Europe and invest up to 17% of their turnover in R&D investment. Medicines for Europe member companies across Europe are both increasing access to medicines and driving improved health outcomes. They play a key role in creating sustainable European healthcare systems by continuing to provide high quality, effective generic medicines, whilst also innovating to create new biosimilar medicines and bringing to market value added medicines, which deliver better health outcomes, greater efficiency and/or improved safety in the hospital setting for patients.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1993
Employees
51-200

Section iconFunding & Financials

  • $10M$25M

    Medicines for Europe's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    Medicines for Europe's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.